Joshua Barocas, MD is an Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center. . He received his medical degree from the George Washington University School of Medicine and Public Health. He completed his Internal Medicine residency and was subsequently Chief Resident at the University of Wisconsin Hospitals and Clinics. Dr. Barocas completed a fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, MA.
He leads an an interdisciplinary research program that is specifically aimed at the goal of improving health outcomes for patients with infectious diseases including HIV and HCV, substance use disorders, and other vulnerable populations. His research, which uses clinical epidemiology, health economics, simulation modeling, and cost-effectiveness, informs clinical-decision making and health policy to answer clinically- and policy-relevant questions. He is engaged in research using these innovative methods to help understand the impact of and improve upon policies that affect people who use drugs infected with or at high risk for HIV and viral hepatitis. His research has been funded by NIDA, NIAID, the Providence/Boston Center for AIDS Research (CFAR), the BU-CTSI, and the MGH Executive Committee on Research Fund for Medical Discovery. He currently serves as Director of the Health Economics and Modeling Core for the Massachusetts HEALing Communities Study, an NIH-funded grant to significantly reduce overdose. He has been the recipient of several research awards including a NIDA Career Development Award (K01), the Charles A. King Trust Research Award, and the prestigious AAMC Herbert W. Nickens Faculty Fellowship Award, which recognizes a junior faculty member who demonstrates leadership potential in addressing inequity in health care. He has published over 30 peer-reviewed articles and editorials, including in leading journals such as NEJM, JAMA Internal Medicine, AJPH, Addiction, Clinical Infectious Diseases, and Annals of Internal Medicine. His work has been widely cited in the media, including the Boston Globe, U.S. News and World Report, and NPR.
- George Washington University School of Medicine, MD
- Washington University in St. Louis, BA
- Published on 12/10/2020
Rubin EJ, Baden LR, Barocas JA, Morrissey S. Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations. N Engl J Med. 2020 12 10; 383(24):e143. PMID: 33296567.
- Published on 12/1/2020
Morgan JR, Barocas JA, Murphy SM, Epstein RL, Stein MD, Schackman BR, Walley AY, Linas BP. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA Netw Open. 2020 Dec 01; 3(12):e2029676. PMID: 33320266.
- Published on 12/1/2020
Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Hadland SE, Barocas JA. Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex. JAMA Netw Open. 2020 Dec 01; 3(12):e2030201. PMID: 33331919.
- Published on 10/26/2020
Komaromy M, Harris, Koenig MRM, Tomanovich MM, Ruiz-Mercado G, Barocas JA. Caring for COVID's most vulnerable victims: a safety-net hospital responds. Res Sq. 2020 Oct 26. PMID: 33140040.
- Published on 10/8/2020
Min JE, Pearce LA, Homayra F, Dale LM, Barocas JA, Irvine MA, Slaunwhite AK, McGowan G, Torban M, Nosyk B. Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis. Drug Alcohol Depend. 2020 Dec 01; 217:108337. PMID: 33049520.
- Published on 10/3/2020
Aldridge AP, Barbosa C, Barocas JA, Bush JL, Chhatwal J, Harlow KJ, Hyder A, Linas BP, McCollister KE, Morgan JR, Murphy SM, Savitzky C, Schackman BR, Seiber EE, E Starbird L, Villani J, Zarkin GA. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug Alcohol Depend. 2020 Dec 01; 217:108336. PMID: 33152672.
- Published on 9/9/2020
Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, Englander H, Linas BP. Long-term infective endocarditis mortality associated with injection opioid use in the United States: a modeling study. Clin Infect Dis. 2020 Sep 09. PMID: 32901815.
- Published on 9/2/2020
Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, Del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda. J Infect Dis. 2020 Sep 02; 222(Supplement_5):S230-S238. PMID: 32877568.
- Published on 9/1/2020
Schranz A, Barocas JA. Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments. Infect Dis Clin North Am. 2020 09; 34(3):479-493. PMID: 32782097.
- Published on 9/1/2020
Barocas JA, Blackstone E, Bouton TC, Kimmel SD, Caputo A, Porter SJ, Walley AY. Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA. J Addict Med. 2020 Sep/Oct; 14(5):e261-e263. PMID: 32530889.
View 35 more publications: View full profile at BUMC